(Q37727283)

English

Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells

scientific article published on 08 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

author name string

Rongjun Liu

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Shudao Xiong

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Lei Zhang

3

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Yiwei Chu

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

publication date

8 February 2010

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Cellular and Molecular Immunology

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

157-162

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

https://scigraph.springernature.com/pub.10.1038/cmi.2009.117

0 references

Nuclear energy and health: and the benefits of low-dose radiation hormesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Dendritic cells: a critical player in cancer therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Optimizing prostate cancer treatment by combining local radiation therapy with systemic vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Endogenous proliferation: burst-like CD4 T cell proliferation in lymphopenic settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Regulatory T cells: friend or foe in immunity to infection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Making room for T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Response of naïve and memory CD8+ T cells to antigen stimulation in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Roentgen therapy for infections: an historical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 August 2017

Big tumor regression induced by GM-CSF gene-modified 3LL tumor cells via facilitating DC maturation and deviation toward CD11c+CD8alpha+ subset

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

14 September 2017

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

14 September 2017

Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

14 September 2017

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

14 September 2017

Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 June 2018

Selective localization of radiolabeled immune lymphocytes into syngeneic tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

23 June 2018

Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4001896

1 September 2018

Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20140010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20140010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20140010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/CMI.2009.117

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37727283&oldid=2109101184"